கூட்டாளர் இல் நோவோ ஹோல்டிங்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கூட்டாளர் இல் நோவோ ஹோல்டிங்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கூட்டாளர் இல் நோவோ ஹோல்டிங்ஸ் Today - Breaking & Trending Today

Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases


Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
- Financing co-led by Novo Holdings, Sofinnova Partners, Droia Ventures and LSP Dementia Fund, with participation from Polaris Partners, Polaris Innovation Fund, Sanofi Ventures, V-Bio Ventures and VIB
- Developing small molecules to repair neuronal dysfunction and resolve neuroinflammation
- Innovative drug discovery platform leveraging insights from novel targets and pathways, resilience to neurodegeneration and all-in-human validation
News provided by
Share this article
Share this article
COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/  Muna Therapeutics ( Muna ), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases, today announced the successful closing of a US$ 73 million (EUR 60 million) Series A financing round. The investor syndicate was co-led by Novo Holdings, Sofinnov ....

New York , United States , France General , Region Flamande , City Of , United Kingdom , San Francisco , Noord Holland , Luc Dochez , Rita Balice Gordon , Isaac Ciechanover , Simon Glerup , Cillian King , Henrijette Richter , Anders Hinsby , Morten Graugaard , Novo Nordisk , Dementia Fund , Partner At Novo Holdings , Novo Group , Investor Syndicate , Polaris Innovation Fund , Loncode Institute , Novo Nordisk Foundation , Novo Holdings , Aarhus University ,

Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases


Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
- Novo Holdings created and built Muna Therapeutics with pioneers in the field of neurodegeneration
- Led by an experienced management team of Entrepreneurs-in-Residence from Novo Seeds
- Financing co-led by Novo Holdings, Sofinnova Partners, Droia Ventures and LSP Dementia Fund, with participation from Polaris Partners, Polaris Innovation Fund, Sanofi Ventures, V-Bio Ventures and VIB
News provided by
Share this article
Share this article
COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/ Novo Holdings, a global life science investor, today announces that it has co-led the Series A financing of its portfolio company, Muna Therapeutics ( Muna ), which is pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases. The financing also includes Sofinnova Partners, Droia Ventures ....

Simon Glerup , Anders Hinsby , Morten Graugaard , Rita Balice Gordon , Novo Nordisk , Dementia Fund , Partner At Novo Holdings , Novo Group , Polaris Innovation Fund , Prnewswire Novo Holdings , Novo Nordisk Foundation , Novo Holdings , Aarhus University , Muna Therapeutics , Sofinnova Partners , Droia Ventures , Polaris Partners , Sanofi Ventures , V Bio Ventures , Professor Simon Glerup , Enovo Seeds , Novo Seed , Professor Bart De Strooper , Chief Executive Officer , Frontotemporal Dementia , Managing Partner ,